Voltage-gated sodium (NaV)- and potassium (KV)-channel proteins underlie the regulation of basal electrical excitability and the initiation and repolarization of action potentials in virtually all excitable cells. These channels have evolved from primordial K+-selective pores into diverse proteins with regulatory mechanisms that enable them to respond to specific stimuli in the nervous, cardiovascular, and immune systems. The importance of this protein family to human health is highlighted by the facts that: inherited or acquired defects in NaV or Kv channels cause epilepsy, myotonia, erythromelalgia and cardiac arrhythmias;mutations that lead to changes in the gating kinetics or expression of K+ channels in excitable tissues such as cardiac muscle can lead to arrhythmias and susceptibility to sudden cardiac death (long or short QT syndromes);and significant electrical remodeling of KV- and NaV-channel expression is observed during cardiac hypertrophy or persistent arrhythmias. Unfortunately, a broad spectrum of excitability disorders remains largely untreatable, and a fresh approach to closing the gap in our understanding of NaV and KV gating and selectivity will be needed if effective therapeutics are to be developed. Notably, although ion channels (particularly those of the voltage-gated ion channel superfamily) have been characterized on both the macroscopic and atomic levels, these studies lack the resolution needed to identify essential chemical property(s) of the amino acids that have been implicated in functional roles. The lack of such information remains a significant block to our understanding of ion permeation and channel gating, and ultimately, effective drug design. Here we propose to design and apply powerful synthetic tools, in the form of tailor-made unnatural amino acids, as a means of achieving hypothesis-driven atomic-level mutagenesis to reach a physiological endpoint: an understanding of the basis of ion selectivity and channel gating. Further, although we expect to eventually be able to perform structure-based drug design, no structures yet exist for eukaryotic NaVs, and the work proposed here will inform us directly about which traits of bacterial NaV's (where structures are now available) are relevant to eukaryotic NaV's. Finally, the results of our study will remove a significant technical barrier to an atomic-level, functional understanding of the gating and permeation mechanisms employed by NaV and KV channels-two proven drug targets in the management of excitability disorders. Success of the proposed study will make it possible to generate novel amino acids that will be widely available to the research community.
The results of our study will remove a significant technical barrier that has barred an atomic-level, functional understanding of sodium and potassium channels-two proven drug targets in the management of excitability disorders such as epilepsy, cardiac arrhythmia and pain. Success of the proposed study will enable the generation of powerful research tools that will be widely available to the research community.
|Steinberg, Ximena; Kasimova, Marina A; Cabezas-Bratesco, Deny et al. (2017) Conformational dynamics in TRPV1 channels reported by an encoded coumarin amino acid. Elife 6:|
|Leisle, Lilia; Chadda, Rahul; Lueck, John D et al. (2016) Cellular encoding of Cy dyes for single-molecule imaging. Elife 5:|
|Ahern, Christopher A; Payandeh, Jian; Bosmans, Frank et al. (2016) The hitchhiker's guide to the voltage-gated sodium channel galaxy. J Gen Physiol 147:1-24|
|Lueck, John D; Mackey, Adam L; Infield, Daniel T et al. (2016) Atomic mutagenesis in ion channels with engineered stoichiometry. Elife 5:|
|Tian, Yutao; Aursnes, Marius; Hansen, Trond Vidar et al. (2016) Atomic determinants of BK channel activation by polyunsaturated fatty acids. Proc Natl Acad Sci U S A 113:13905-13910|
|Leisle, Lilia; Valiyaveetil, Francis; Mehl, Ryan A et al. (2015) Incorporation of Non-Canonical Amino Acids. Adv Exp Med Biol 869:119-51|
|Zhang, Roger S; Wright, Jordan D; Pless, Stephan A et al. (2015) A Conserved Residue Cluster That Governs Kinetics of ATP-dependent Gating of Kir6.2 Potassium Channels. J Biol Chem 290:15450-61|
|Kim, Robin Y; Yau, Michael C; Galpin, Jason D et al. (2015) Atomic basis for therapeutic activation of neuronal potassium channels. Nat Commun 6:8116|
|Pless, Stephan A; Kim, Robin Y; Ahern, Christopher A et al. (2015) Atom-by-atom engineering of voltage-gated ion channels: magnified insights into function and pharmacology. J Physiol 593:2627-34|
|Pless, Stephan A; Ahern, Christopher A (2015) Introduction: Applying Chemical Biology to Ion Channels. Adv Exp Med Biol 869:1-4|
Showing the most recent 10 out of 14 publications